News Archive

 
Featured
FAQs for PrEPVacc's vaccine result
FAQs for PrEPVacc's vaccine result
Media coverage of PrEPVacc's July 2024 vaccine result announcement
Media
Media coverage of PrEPVacc's July 2024 vaccine result announcement
Media
Media
Taarifa kwa Umma: Chanjo za VVU zilizojaribiwa katika utafiti wa PrEPVacc zashindwa kupunguza maambukizi
Taarifa kwa Umma: Chanjo za VVU zilizojaribiwa katika utafiti wa PrEPVacc zashindwa kupunguza maambukizi
News Release: HIV vaccines tested in PrEPVacc fail to reduce infections
Research
News Release: HIV vaccines tested in PrEPVacc fail to reduce infections
Research
Research
AIDS 2024: “I am not sick, why should I swallow daily pills?”: non-uptake of, and adherence to daily oral pre-exposure prophylaxis among adults at high-risk of HIV in Masaka, Uganda
Research
AIDS 2024: “I am not sick, why should I swallow daily pills?”: non-uptake of, and adherence to daily oral pre-exposure prophylaxis among adults at high-risk of HIV in Masaka, Uganda
Research
Research
AIDS 2024: Knowledge and experiences of participating in an HIV vaccine efficacy trial with second randomization to oral pre-exposure prophylaxis in South Africa, Tanzania, and Uganda
Research
AIDS 2024: Knowledge and experiences of participating in an HIV vaccine efficacy trial with second randomization to oral pre-exposure prophylaxis in South Africa, Tanzania, and Uganda
Research
Research
AIDS 2024: HIV risk perception, trust and PrEP adherence among participants in an HIV prevention trial: a qualitative longitudinal study, South Africa
Research
AIDS 2024: HIV risk perception, trust and PrEP adherence among participants in an HIV prevention trial: a qualitative longitudinal study, South Africa
Research
Research
AIDS 2024: Disclosing of Participation in an HIV Vaccine Trial in Southwestern Uganda – the effect on participant engagement
Research
AIDS 2024: Disclosing of Participation in an HIV Vaccine Trial in Southwestern Uganda – the effect on participant engagement
Research
Research
AVAC briefing on PrEPVacc: An in-depth look at the trial, and what’s next
AVAC briefing on PrEPVacc: An in-depth look at the trial, and what’s next
Media coverage of PrEPVacc's December 2023 study update
Media
Media coverage of PrEPVacc's December 2023 study update
Media
Media